» Articles » PMID: 33532842

Chest Wall Resection and Reconstruction for Primary and Metastatic Sarcomas: an 11-year Retrospective Cohort Study

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Chest wall sarcomas are rare, aggressive malignancies, the management of which mainly revolves around surgery. Radical tumour excision with free margins represents the optimal treatment for loco-regional clinically resectable disease. The objective of this study was to review our 11-year experience with chest wall resection for primary and metastatic sarcomas, focusing on surgical techniques and strategies for reconstruction.

Methods: Retrospective analysis of a comprehensive database of patients who underwent chest wall resection for primary or secondary sarcoma at our Institute from January 2009 to December 2019.

Results: Out of 26 patients, 21 (81%) suffered from primary chest wall sarcoma, while 5 (19%) had recurring disease. The median number of resected ribs was 3. Sternal resection was performed in 6 cases (23%). Prosthetic thoracic reconstruction was deemed necessary in 24 cases (92%). Tumour recurrence was observed in 15 patients (58%). The median overall survival was 73.6 months. Primary and secondary tumours showed comparable survival (P = 0.49). At univariate analysis, disease recurrence and infiltrated margins on pathological specimens were associated with poorer survival (P = 0.014 and 0.022, respectively). In patients with primary sarcoma, the median progression-free survival was 13.3 months. Associated visceral resections were significantly associated to postoperative complications (P = 0.02).

Conclusions: Chest wall resection followed by prosthetic reconstruction is feasible in carefully selected patients and should be performed by experienced surgeons with the aim of achieving free resection margins, resulting in improved long-term outcomes.

Citing Articles

Surgical Outcomes after Full Thickness Chest Wall Resection Followed by Immediate Reconstruction: A 7-Year Observational Study of 42 Cases.

Sparreboom C, Hop M, Mazaheri M, Rothbarth J, Maat A, Corten E JPRAS Open. 2024; 41:14-24.

PMID: 38845680 PMC: 11153933. DOI: 10.1016/j.jpra.2024.04.006.


Oncological results in primary and secondary malignant chest wall tumors.

Kocaman G, Kahya Y, Konuk Balci B, Yenigun B, Ozkan M, Ozakinci H Turk Gogus Kalp Damar Cerrahisi Derg. 2024; 32(1):55-61.

PMID: 38545355 PMC: 10964308. DOI: 10.5606/tgkdc.dergisi.2024.25393.


Outcome Analysis of Treatment Modalities for Thoracic Sarcomas.

Sarvan M, Etienne H, Bankel L, Brown M, Schneiter D, Opitz I Cancers (Basel). 2023; 15(21).

PMID: 37958328 PMC: 10649966. DOI: 10.3390/cancers15215154.


The sternum reconstruction: Present and future perspectives.

Aramini B, Masciale V, Radaelli L, Sgarzani R, Dominici M, Stella F Front Oncol. 2022; 12:975603.

PMID: 36387077 PMC: 9649912. DOI: 10.3389/fonc.2022.975603.

References
1.
Foroulis C, Kleontas A, Tagarakis G, Nana C, Alexiou I, Grosomanidis V . Massive chest wall resection and reconstruction for malignant disease. Onco Targets Ther. 2016; 9:2349-58. PMC: 4846065. DOI: 10.2147/OTT.S101615. View

2.
Shewale J, Mitchell K, Nelson D, Conley A, Rice D, Antonoff M . Predictors of survival after resection of primary sarcomas of the chest wall-A large, single-institution series. J Surg Oncol. 2018; 118(3):518-524. DOI: 10.1002/jso.25162. View

3.
Mansour K, Thourani V, Losken A, Reeves J, Miller Jr J, Carlson G . Chest wall resections and reconstruction: a 25-year experience. Ann Thorac Surg. 2002; 73(6):1720-5; discussion 1725-6. DOI: 10.1016/s0003-4975(02)03527-0. View

4.
Khullar O, Fernandez F . Prosthetic Reconstruction of the Chest Wall. Thorac Surg Clin. 2017; 27(2):201-208. DOI: 10.1016/j.thorsurg.2017.01.014. View

5.
Casali P, Abecassis N, Aro H, Bauer S, Biagini R, Bielack S . Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018; 29(Suppl 4):iv51-iv67. DOI: 10.1093/annonc/mdy096. View